日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis

单细胞转录组分析揭示了胰腺导管腺癌转移过程中免疫抑制微环境的演变

Xiaowei Liu # ,Jinen Song # ,Meiling Yuan ,Fengli Zuo ,Huihui Li ,Leyi Tang ,Xinmin Wang ,Xueyan Wang ,Qian Xiao ,Li Li ,Xinyu Liu ,Zhankun Yang ,Jianlin Wu ,Jing Jing ,Xuelei Ma ,Hubing Shi

A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer

一种基于顺铂前药的自组装臭氧递送纳米系统可增强三阴性乳腺癌的放射治疗效果

Tianyue Xu ,Dan Zheng ,Meixu Chen ,Linlin Song ,Zhihui Liu ,Yan Cheng ,Yujie Zhao ,Liwen Huang ,Yixuan Li ,Zhankun Yang ,Cong Li ,Biao Dong ,Jing Jing ,Hubing Shi

Intrapleural pressure-controlled piezo-catalytic nanozyme for the inhibition of malignant pleural effusion

胸膜腔内压力控制的压电催化纳米酶用于抑制恶性胸膜积液

Zihan Xu # ,Xiujing He # ,Yu Gui # ,Lingkai Tang # ,Yuxin Zhao ,Linlin Song ,Tianyue Xu ,Meixu Chen ,Yujie Zhao ,Peixin Du ,Xin Wang ,Siyi Chen ,Yong Luo ,Feng Luo ,Huan Meng ,Jianping Hu ,Wei Zhuo ,Jing Jing ,Hubing Shi

Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC

外泌体介导的 miR-519e-5p 递送促进转移性 PTC 中的恶性肿瘤表型和 CD8+ T 细胞耗竭

Genpeng Li, Wenjie Chen, Ke Jiang, Jing Huang, Jinjing Zhong, Xiaowei Liu, Tao Wei, Rixiang Gong, Zhihui Li, Jingqiang Zhu, Hubing Shi, Jianyong Lei

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance

免疫检查点 HLA-E:CD94-NKG2A 介导循环肿瘤细胞逃避 NK 细胞监视

Xiaowei Liu, Jinen Song, Hao Zhang, Xinyu Liu, Fengli Zuo, Yunuo Zhao, Yujie Zhao, Xiaomeng Yin, Xinyu Guo, Xi Wu, Hu Zhang, Jie Xu, Jianping Hu, Jing Jing, Xuelei Ma, Hubing Shi

Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing

利用单细胞RNA测序技术鉴定人胰腺导管腺癌循环肿瘤细胞免疫检查点的方案

Xiaowei Liu ,Jinen Song ,Xinyu Liu ,Hao Zhang ,Xueyan Wang ,Yuanxi Li ,Zhankun Yang ,Jing Jing ,Xuelei Ma ,Hubing Shi

PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer

PSMG2 控制的蛋白酶体自噬平衡介导三阴性乳腺癌对 MEK 靶向治疗的耐受性

Xueyan Wang, Jing Yu, Xiaowei Liu, Dan Luo, Yanchu Li, Linlin Song, Xian Jiang, Xiaomeng Yin, Yan Wang, Li Chai, Ting Luo, Jing Jing, Hubing Shi

Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade

MAPK 抑制与光热疗法相结合可协同增强免疫检查点阻断的抗肿瘤功效

Xiaowei Liu, Yanlin Feng, Jie Xu, Ying Shi, Jiqiao Yang, Rongjie Zhang, Jinen Song, Xin Bai, Xi Wu, Yu Bao, Ya Luo, Huifang Li, Li Chai, Changyang Gong, Yan Wang, Bo Chen, Jianping Hu, Yan Fu, Yongzhang Luo, Haiyuan Zhang, Hubing Shi

Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor

mTOR抑制剂提高PD-1阻断疗效及消除免疫相关胃肠道不良反应

Xin Bai, Xueyan Wang, Guozhen Ma, Jinen Song, Xiaowei Liu, Xi Wu, Yujie Zhao, Xu Liu, Zhihui Liu, Wei Zhang, Xin Zhao, Zirui Zheng, Jing Jing, Hubing Shi

Integrin-Src-YAP1 signaling mediates the melanoma acquired resistance to MAPK and PI3K/mTOR dual targeted therapy

整合素-Src-YAP1信号介导黑色素瘤对MAPK和PI3K/mTOR双靶向治疗的获得性耐药

Chune Yu #, Min Zhang #, Jinen Song #, Xiaobo Zheng #, Guangchao Xu, Yu Bao, Jiang Lan, Dan Luo, Jianping Hu, Jingyi Jessica Li, Hubing Shi